无疾病活动证据与多发性硬化视网膜轴索萎缩减缓相关
一项纵向研究纳入72例多发性硬化患者,其中63例每年常规脑MRI,基线和2年后行OCT、VEP和EDSS评估。随访期间无视神经炎患者中,双眼平均RNFL变薄与EDSS恶化相关(Spearman ρ -0.462,p < 0.001)。NEDA患者RNFL丢失-0.93 μm ± 1.35 SD,活动性疾病患者为-2.83 μm ± 2 SD(t检验;p < 0.001)。
要点
- NEDA与2年内RNFL相对保留相关,活动性疾病患者RNFL丢失更明显。
- RNFL变薄与EDSS恶化相关,独立于基线EDSS、RNFL、病程和MS亚型。
- RNFL平均减少可正确分类76.2%的患者为NEDA(R2 0.355;p = 0.003)。
核心结论
- NEDA与2年内RNFL相对保留相关。
- 即使脑MRI病灶无变化,临床疾病活动患者仍可检测到更大的神经视网膜丢失。
研究设计与样本
- 纵向研究,纳入72例多发性硬化患者,其中63例有常规年度脑MRI。
- 基线和2年后评估OCT、VEP和EDSS。
主要发现
- 随访期间无视神经炎患者中,双眼平均RNFL变薄与EDSS恶化相关(Spearman ρ -0.462,p < 0.001;偏相关系数-0.437,p < 0.001)。
- NEDA患者(20例;31.7%)RNFL丢失-0.93 μm ± 1.35 SD,活动性疾病患者-2.83 μm ± 2 SD(t检验;p < 0.001)。
- RNFL平均减少正确分类76.2%的患者为2年时NEDA(R2 0.355;p = 0.003)。
- RNFL丢失截断值-1.25 μm分类NEDA状态的特异性81.4%、敏感性80%(ROC曲线下面积0.8;p < 0.001)。
- RNFL变化与VEP潜伏期或评分变化无显著纵向相关性。
关键数值与推荐
- NEDA患者RNFL丢失-0.93 μm ± 1.35 SD,活动性疾病患者-2.83 μm ± 2 SD(t检验;p < 0.001)。
- RNFL丢失截断值-1.25 μm分类NEDA状态:特异性81.4%、敏感性80%(ROC曲线下面积0.8;p < 0.001)。
临床怎么用
- OCT可作为MS监测的附加工具,辅助评估疾病活动。
- RNFL变薄可反映神经轴索丢失,即使脑MRI病灶无变化。
局限性
- 样本量较小(72例,其中63例有MRI)。
- 需进一步验证OCT作为MS监测工具的效用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To explore, in a longitudinal study, the usefulness of optical coherence tomography (OCT) in monitoring people with multiple sclerosis (MS) by testing the association between retinal nerve fiber layer (RNFL) thinning and clinical and brain MRI criteria of no evidence of disease activity (NEDA). METHODS: OCT, visual evoked potentials (VEPs), and disability, using the Expanded Disability Status Scale (EDSS), were tested at baseline and after 2 years in 72 patients, 63 with routine yearly brain MRI. RESULTS: Longitudinal mean binocular RNFL thinning, in absence of optic neuritis during follow-up, was correlated with EDSS worsening, also controlling for baseline EDSS, RNFL, disease duration, and MS subtype (Spearman ρ -0.462, p < 0.001; partial correlation coefficient -0.437, p < 0.001). At follow-up, patients classified as NEDA (20; 31.7%) had RNFL loss of -0.93 μm ± 1.35 SD, while patients with active disease had -2.83 μm ± 2 SD thinning (t test; p < 0.001). At logistic regression, mean RNFL reduction correctly classified 76.2% of patients as NEDA at 2 years (R2 0.355; p = 0.003). A cutoff of -1.25 μm RNFL loss classified NEDA status with specificity 81.4% and sensitivity 80% (receiver operating characteristic curve: area under the curve 0.8; p < 0.001). No significant longitudinal correlations were found between changes in RNFL and in VEP latencies or scores. CONCLUSIONS: NEDA is associated with a relatively preserved RNFL over 2 years. A greater neuroretinal loss was detected even in patients with clinical evidence of disease activity independently from changes in brain MRI lesions, prompting further validation of OCT as an additional tool in MS monitoring.
引用
- Pisa M, Guerrieri S, Di Maggio G, et al. No evidence of disease activity is associated with reduced rate of axonal retinal atrophy in MS. Neurology. 2017. PMID: 29142087. doi:10.1212/WNL.0000000000004736
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。